CEACAM5 and adenosquamous lung carcinoma: As shown in Table 2, preoperative NSE, CEA, Cyfra21-1 and SCCA levels were elevated in 35.8%, 47.2%, 54.7% and 15.1% of adenosquamous lung carcinoma patients, respectively.